Skip to main content
OpenTrials
Completed

NCT Number: NCT05226091

Trial to Assess Implementation of New Research in a Primary Care Setting (TRAINS)

In England and Wales, unscheduled care for school-aged children with asthma significantly increases after their return to school in September, a trend linked with decreased asthma preventer prescriptions during the summer holidays. The PLEASANT study found that a reminder letter from GPs to parents of children with asthma led to a 30% increase in prescription uptake during August and reduced unscheduled medical visits from September to December.

The TRAINS trial will now assess if informing GPs of PLEASANT findings would lead to its implementation. This pragmatic cluster randomised implementation trial will use routine data from Clinical Practice Research Datalink (CPRD).

Completed

Looking for future studies?

Notify Me

Key information

Age range

4 year–16 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Sheffield

Sheffield, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Inclusion criteria of practices Practices inclusion criteria

1- General practices who are currently contributing part of the CPRD in England.

  • Inclusion criteria of children with asthma

Inclusion criteria

for the data extraction from CPRD:

1- School-aged children with asthma aged between 4 to 16 years old as of 1st September 2021 with a coded diagnosis of asthma who have been prescribed asthma medication in the last 12 months.

Exclusion criteria

  • Practice exclusion criteria:
  • General practices that are not in England.
  • General practices that are not included in the CPRD.
  • Practices that cease to be part of the CPRD during the intervention time without contributing to the primary outcome.
  • Practices that merge during the intervention (where the merging practices were in different study arms).
  • Exclusion criteria of children with asthma:
  • School-aged children with asthma under 4 and over 16 years old as of 1st September 2021.
  • Children with no asthma diagnosis
  • Children with asthma who have not received a prescription for asthma medication. in the last 12 months

Treatment and study plan

Letter

Behavioral

Selected GP practices currently registered with CPRD will receive correspondence by both email and mail informing them about the result of the PLEASANT study and advising them how to implement what has been learnt. Included in the mailing would be a suggested letter and SMS text.

Primary outcomes

  1. The proportion of children with asthma who have a prescription for an asthma preventer medication from 1st August 2021 to 30th September 2021.

    Time frame: 8 weeks

    prescription uptake of asthma preventer medication for children with asthma.

Secondary outcomes

  1. The number of asthma preventer medication prescriptions per School-aged child with asthma patient from 1st August 2021 to 30th September 2021.

    Time frame: 8 weeks

    preventer medication prescriptions per School-aged child with asthma patient.

  2. The number of prescription uptake of asthma preventer medication per patient in the month of August 2021.

    Time frame: 4 weeks

    prescription uptake of asthma preventer medication per patient.

  3. The number of prescription uptake of asthma preventer medication per patient in the month of September 2021

    Time frame: 4 weeks

    prescription uptake of asthma preventer medication per patient.

  4. The proportion of children who have a prescription for asthma preventer medication per patient in the month of August 2021.

    Time frame: 4 weeks

    The proportion of children who have a prescription for asthma preventer medication per patient

  5. The proportion of children who have a prescription for asthma preventer medication per patient in the month of September 2021.

    Time frame: 4 weeks

    children who have a prescription for asthma preventer medication per patient

  6. The number of prescription uptake of asthma preventer medication in the 6 months following the intervention 1st July 2021.

    Time frame: 6 months

    The number of prescription uptake of asthma preventer medication

  7. The proportion of patients with unscheduled medical contact from 1st September 2021 to 30th December 2021 and the individual months of 1st September 2021 to 31st December 2021.

    Time frame: 4 months

    The proportion of patients with unscheduled medical contact

  8. The number of unscheduled medical contact per patient from 1st September 2021 to 31th December 2021 and the individual months from 1st September 2021 to 31st December 2021.

    Time frame: 4 months and each one of them

    The number of unscheduled medical contact per patient

  9. The proportion of patients who have a medical contact (either unscheduled and scheduled) from 1st September 2021 to 30th December 2021 and the individual months from 1st September 2021 to 31st December 2021.

    Time frame: 4 months and each one of them

    The proportion of patients who have a medical contact (either unscheduled and scheduled)

  10. The total number of medical contact (either unscheduled and scheduled) per patient in the period 1st September 2021 to 30th December 2021 and the individual months of 1st September 2021 to 31st December 2021.

    Time frame: 4 months and each one of them

    The total number of medical contact (either unscheduled and scheduled) per patient

  11. The proportion of patients who have an unscheduled medical contact in the period 1st September 2021 to 30th December 2021 and the individual months of 1st September 2021 to 30th December 2021 associated with a respiratory diagnosis.

    Time frame: 4 months and each one of them

    The proportion of patients who have an unscheduled medical contact associated with a respiratory diagnosis.

  12. The number of unscheduled medical contacts per patient and from 1st September 2021 to 30th December 2021 and the individual months of 1st September 2021 to 31st December 2021associated with a respiratory diagnosis.

    Time frame: 4 months and each one of them

    The number of unscheduled medical contacts per patient associated with a respiratory diagnosis.

Sponsors and collaborators

Lead sponsor

University of Sheffield

Other

Registry information

Official study title

TRial to Assess Implementation of New Research in a Primary Care Setting (TRAINS): a Pragmatic Cluster Randomised Controlled Trial of an Educational Intervention to Promote Asthma Prescription Uptake in General Practitioner Practices

Acronym: (TRAINS)

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Feb 7, 2022
Registry last updated
May 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.